Mitsubishi UFJ Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $612K | Buy |
18,692
+5,237
| +39% | +$189K | ﹤0.01% | 893 |
|
|
2026
Q1 | $476K | Buy |
13,455
+2,027
| +18% | +$82.5K | ﹤0.01% | 876 |
|
|
2025
Q4 | $463K | Buy |
11,428
+5,039
| +79% | +$219K | ﹤0.01% | 894 |
|
|
2025
Q3 | $300K | Buy |
6,389
+19
| +0.3% | +$985 | ﹤0.01% | 945 |
|
|
2025
Q2 | $332K | Buy |
6,370
+908
| +17% | +$49.8K | ﹤0.01% | 912 |
|
|
2025
Q1 | $330K | Buy |
5,462
+239
| +5% | +$15.4K | ﹤0.01% | 894 |
|
|
2024
Q4 | $355K | Buy |
5,223
+114
| +2% | +$7.95K | ﹤0.01% | 914 |
|
|
2024
Q3 | $367K | Buy |
5,109
+96
| +2% | +$6.77K | ﹤0.01% | 894 |
|
|
2024
Q2 | $348K | Buy |
5,013
+2,060
| +70% | +$150K | ﹤0.01% | 903 |
|
|
2024
Q1 | $236K | Sell |
2,953
-137
| -4% | -$12.2K | ﹤0.01% | 945 |
|
|
2023
Q4 | $335K | Buy |
3,090
+40
| +1% | +$4.14K | ﹤0.01% | 960 |
|
|
2023
Q3 | $308K | Buy |
3,050
+3
| +0.1% | +$345 | ﹤0.01% | 982 |
|
|
2023
Q2 | $414K | Sell |
3,047
-1,605
| -35% | -$196K | ﹤0.01% | 945 |
|
|
2023
Q1 | $483K | Hold |
4,652
| – | – | ﹤0.01% | 906 |
|
|
2022
Q4 | $418K | Buy |
4,652
+1,379
| +42% | +$114K | ﹤0.01% | 946 |
|
|
2022
Q3 | $262K | Buy |
3,273
+185
| +6% | +$17.5K | ﹤0.01% | 993 |
|
|
2022
Q2 | $296K | Buy |
3,088
+11
| +0.4% | +$1.32K | ﹤0.01% | 995 |
|
|
2022
Q1 | $457K | Hold |
3,077
| – | – | ﹤0.01% | 958 |
|
|
2021
Q4 | $449K | Buy |
3,077
+421
| +16% | +$59.6K | ﹤0.01% | 963 |
|
|
2021
Q3 | $347K | Sell |
2,656
-149
| -5% | -$19.5K | ﹤0.01% | 994 |
|
|
2021
Q2 | $385K | Sell |
2,805
-76
| -3% | -$10.4K | ﹤0.01% | 992 |
|
|
2021
Q1 | $376K | Buy |
2,881
+1,101
| +62% | +$133K | ﹤0.01% | 928 |
|
|
2020
Q4 | $199K | Sell |
1,780
-227
| -11% | -$21.5K | ﹤0.01% | 955 |
|
|
2020
Q3 | $158K | Sell |
2,007
-578
| -22% | -$47.1K | ﹤0.01% | 922 |
|
|
2020
Q2 | $186K | Buy |
2,585
+721
| +39% | +$50.2K | ﹤0.01% | 902 |
|
|
2020
Q1 | $107K | Buy |
1,864
+336
| +22% | +$31K | ﹤0.01% | 926 |
|
|
2019
Q4 | $170K | Sell |
1,528
-328
| -18% | -$35K | ﹤0.01% | 898 |
|
|
2019
Q3 | $178K | Buy |
1,856
+85
| +5% | +$7.98K | ﹤0.01% | 839 |
|
|
2019
Q2 | $152K | Sell |
1,771
-154
| -8% | -$12.7K | ﹤0.01% | 860 |
|
|
2019
Q1 | $160K | Buy |
1,925
+183
| +11% | +$13.3K | ﹤0.01% | 820 |
|
|
2018
Q4 | $106K | Buy |
1,742
+454
| +35% | +$31.1K | ﹤0.01% | 841 |
|
|
2018
Q3 | $102K | Buy |
+1,288
| New | +$99.6K | ﹤0.01% | 849 |
|
|
2015
Q2 | – | Sell |
-22,500
| Closed | -$1.14M | – | 855 |
|
|
2015
Q1 | $1.14M | Buy |
+22,500
| New | +$1.1M | 0.03% | 523 |
|
Other funds holding CNMD
ICM
Mitsubishi UFJ Asset Management's CNMD Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its CONMED (CNMD) stake by 39% in Q2 2026, buying an estimated $189K and bringing the position to 18,692 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #893.
Mitsubishi UFJ Asset Management first reported a position in CNMD in Q1 2015 and has held it in 33 quarters since. The position peaked at $1.14M in Q1 2015. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Mitsubishi UFJ Asset Management held 18,692 shares of CONMED worth $612K as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 5,237 CONMED shares in Q2 2026, an estimated $189K.
- CONMED made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #893 holding.
- Mitsubishi UFJ Asset Management first reported a position in CONMED in Q1 2015 and has held it in 33 quarters since.
- Mitsubishi UFJ Asset Management's CONMED position peaked at $1.14M in Q1 2015.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.